Reverse transcriptase template switching during reverse transcriptase–polymerase chain reaction: Artificial generation of deletions in ribonucleotide reductase mRNA

作者: Robert M. Mader , Wolfgang M. Schmidt , Roland Sedivy , Blanka Rizovski , Johanna Braun

DOI: 10.1067/MLC.2001.115452

关键词:

摘要: Using reverse transcriptase-polymerase chain reaction (RT-PCR), we have recently described a bona fide deletion within the coding sequence of large subunit ribonucleotide reductase (R1) mRNA in colon cancer. Consecutive studies raised questions about nature this phenomenon, because corresponding genomic alteration at DNA level or an aberrant protein could not be detected. Thus considered vitro artifact during RT-PCR as possible explanation for observation. In contrast to transcriptase, Taq polymerase C. therm did generate product, suggesting demand template switching activity intrinsic retroviral transcriptases. fact, virtually same was observed experiments when transcribed R1 used. Considering structural prerequisites mRNA, show that two direct repeats adjacent strong stem-loop secondary structure flank deleted region 1851 base pairs. Because several mRNAs encoding proteins clinical and diagnostic importance fulfill these criteria, enhances potential risk observing artifacts interpreting results from studies. As shown present example, may involve artificial generation misinterpretation PCR fragments amplified targets relevant tumor biology cancer pharmacology. solution, one-step with should considered. This eliminates signals cDNA synthesis.

参考文章(14)
RD Rubens, , SB Kaye, M Soukop, CJ Williams, MH Brampton, AL Harris, Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. British Journal of Cancer. ,vol. 64, pp. 1187- 1188 ,(1991) , 10.1038/BJC.1991.488
R.A. Hurta, S.K. Samuel, A.H. Greenberg, J.A. Wright, Early induction of ribonucleotide reductase gene expression by transforming growth factor beta 1 in malignant H-ras transformed cell lines. Journal of Biological Chemistry. ,vol. 266, pp. 24097- 24100 ,(1991) , 10.1016/S0021-9258(18)54398-2
S Eriksson, A Gräslund, S Skog, L Thelander, B Tribukait, Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. Journal of Biological Chemistry. ,vol. 259, pp. 11695- 11700 ,(1984) , 10.1016/S0021-9258(20)71265-2
Jennifer A. Dumont, Tammy L. Bush, Donald P. Matthews, Donald A. Kaplan, Alan J. Bitonti, James R. McCarthy, Paul S. Wright, Doreen E. Cross-Doersen, Elizabeth A. Cashman, Regression of Human Breast Tumor Xenografts in Response to (E)-2′-Deoxy-2′-(fluoromethylene)cytidine, an Inhibitor of Ribonucleoside Diphosphate Reductase Cancer Research. ,vol. 54, pp. 1485- 1490 ,(1994)
J Carmichael, K Possinger, P Phillip, M Beykirch, H Kerr, J Walling, A L Harris, Advanced breast cancer: a phase II trial with gemcitabine. Journal of Clinical Oncology. ,vol. 13, pp. 2731- 2736 ,(1995) , 10.1200/JCO.1995.13.11.2731
Stephen J. Elledge, Zheng Zhou, James B. Allen, Tony A. Navas, DNA damage and cell cycle regulation of ribonucleotide reductase BioEssays. ,vol. 15, pp. 333- 339 ,(1993) , 10.1002/BIES.950150507
Robert M. Mader, Anna E. Sieder, Johanna Braun, Blanka Rizovski, Maria Kalipciyan, Manfred W. Mueller, Raimund Jakesz, Hugo Rainer, Guenther G. Steger, Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro Biochemical Pharmacology. ,vol. 54, pp. 1233- 1242 ,(1997) , 10.1016/S0006-2952(97)00330-4
C. H. Baker, J. Banzon, J. M. Bollinger, J. Stubbe, V. Samano, M. J. Robins, B. Lippert, E. Jarvi, R. Resvick, 2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase. Journal of Medicinal Chemistry. ,vol. 34, pp. 1879- 1884 ,(1991) , 10.1021/JM00110A019
Bob K. Choy, Grant A. McClarty, Jim A. Wright, Transient elevation of ribonucleotide reductase activity, M2 mRNA and M2 protein in BALB/c 3T3 fibroblasts in the presence of 12-O-tetradecanoylphorbol-13-acetate Biochemical and Biophysical Research Communications. ,vol. 162, pp. 1417- 1424 ,(1989) , 10.1016/0006-291X(89)90832-2